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Abstract
Background: Microbicide candidates delivered via gel vehicles are intended to coat the vaginal epithelium after application.
The coating process depends on intrinsic biophysical properties of the gel texture, which restricts the potential choices for
an effective product: the gel first must be physically synthesizable, then acceptable to the user, and finally applied in a
manner promoting timely adequate coating, so that the user adherence is optimized. We present a conceptual framework
anchoring microbicide behavioral acceptability within the fulfillment of the product biophysical requirements.
Methods: We conducted a semi-qualitative/quantitative study targeting women aged 18–55 in Northern California to assess
user preferences for microbicide gel attributes. Attributes included: (i) the wait time between application and intercourse,
(ii) the gel texture and (iii) the trade-off between wait time and gel texture. Wait times were assessed using a mathematical
model determining coating rates depending upon the gel’s physical attributes.
Results: 71 women participated. Results suggest that women would independently prefer a gel spreading rapidly, in 2 to
15 minutes (P,0.0001), as well as one that is thick or slippery (P,0.02). Clearly, thick gels do not spread rapidly; hence the
motivation to study the trade-off. When asked the same question ‘constrained’ by the biophysical reality, women indicated
no significant preference for a particular gel thickness (and therefore waiting time) (P.0.10) for use with a steady partner, a
preference for a watery gel spreading rapidly rather than one having intermediate properties for use with a casual partner
(P=0.024).
Conclusions: Biophysical constraints alter women’s preferences regarding acceptable microbicide attributes. Product
developers should offer a range of formulations in order to address all preferences. We designed a conceptual framework to
rethink behavioral acceptability in terms of biophysical requirements that can help improve adherence in microbicide use
ultimately enhancing microbicide effectiveness.
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Introduction
As women now account for 60% (75% between the ages of 15
and 24 [1]) of the 22.4 million infected subjects in sub-Saharan
Africa [1], a new approach such as a vaginal microbicide
empowering women against HIV infection has become a necessity.
Microbicides are chemical agents used intravaginally with a goal
to protect users against sexually transmitted infections (STIs)
including HIV [2]. Multipurpose prevention microbicides, also
referred to as ‘combinations’, are in development which may
provide protection from HIV, some sexually transmitted infec-
tions, as well as unplanned pregnancy and other reproductive tract
infections [3]. They can be classified according to different
mechanisms of action: non-specific microbicides, moderately
specific microbicides, highly specific anti-HIV agents, etc [4].
After disappointing results for all the efficacy trials conducted
evaluating detergent and polyanionic formulations [5–7], the
CAPRISA 004 trial, evaluating an antiretroviral drug-based
microbicide [8], recently proved to be successful with a 28–54%
range of effectiveness depending on the user’s adherence [9].
About 77 other microbicide candidates are currently in the clinical
or preclinical pipeline [10]. Multiple challenges lie ahead in terms
of clinical trials and product development [11,12] among which
the issue of the user’s adherence [9,13].
Recently, research has paid great attention to the delivery
systems for the active ingredients such as gels or intravaginal rings,
and has focused on aspects of coital dependency, compliance, cost
and adaptability to large-scale production for instance [14].
Indeed, the delivery systems are crucial: in order for the active
ingredients to work effectively, they must be adequately distributed
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occurs in the vagina [15]. In the particular case of gel vehicles, the
effectiveness of the microbicide would depend on fundamental
biophysical properties of the gel texture, such as the coating
process [15] as well as on gravity, adhesion, and shearing forces
from surrounding tissues [16]. At the same time, a microbicide gel
will not be effective unless applied consistently and correctly by the
user: this is especially important in clinical trials [17] where a fall-
out in adherence can significantly ‘dilute’ efficacy measurements
[13,18] as observed in the CAPRISA 004 trial [9]. In that regard,
biophysical properties and the social/behavioral attributes of
microbicide products are thus intrinsically linked. For example,
how quickly the gel spreads, or its viscosity, will in turn have
potential impact on the adherence by the intended consumer: a
product that is highly viscous may require several hours to spread
effectively, thus impacting the waiting time before protected sexual
intercourse [19]. Longer waiting times may be less well adhered to,
or better, depending on the context and the user. Conversely, a
less viscous product could spread more rapidly and require a
shorter waiting period [19], but would likely be more messy. The
preference over this range of constrained possibilities may differ by
user or by specific situation.
Most studies have assessed acceptability using either candidate
microbicides [20–23] or surrogate products [24,25]. In addition,
because microbicides are an evolving technology, earlier studies
focused on soliciting input from individuals about hypothetical
products using traditional epidemiological and behavioral research
methodologies [26–28]. Some studies have focused on some
specific population segments such as women at high risk [29],
adolescents [30] etc.; on the context of sexual relationships [31]; or
on the involvement of male partners [32,33]. Others have looked
at characteristics of the product itself and precisely on the ‘vehicle-
associated factors’ such as the product’s ‘color’, ‘smell’, consisten-
cy’, ‘leakage’ potential [34,35]. Previous research has applied
mixed methods using both quantitative and qualitative data
[34,36] or a more market-oriented research method with ‘conjoint
analysis’ [36,37] to study hypothetical users’ preferences. Reviews
of microbicide acceptability research have emphasized the social-
cultural factors [38] and recommended the use of a comprehensive
and integrated approach assessing ‘vehicle-associated’, ‘applica-
tion-associated’ and ‘use-associated’ factors [39]. However, very
little work to this day [40,41] has started to explore in detail what
biophysical properties of microbicide gels women are likely to
prefer, given the range of realistic possibilities. In other words, how
do constraints imposed by biophysical requirements alter the
preferences users might have about microbicides?
We introduce through this study a new conceptual framework
to assessing microbicide acceptability and use by evaluating the
interplay between social and biophysical acceptability. Specifically,
we integrate a well-established semi qualitative-quantitative
framework [34,36] with the biophysical reality of the gels
described by a mathematical model of vaginal wall coating [19].
Essentially, our goal is to assess the trade-offs potential users would
make between the thickness (viscosity) of the gel and the wait time
needed for the gel to coat the vaginal epithelium (a proxy for the
waiting time before sexual intercourse). The viscosity of the gel
both provides the texture of the gel and governs the kinetics of the
flow. It provides the physical attribute that links user preferences
with physical functionality. We first ask in a series of questions
about desirable attributes (thickness and coating time) indepen-
dently. Next we explore changes in the preferences that emerge
when biophysical constraints, assessed with the computer model
[19], are taken into account. The concept of a ‘constrained’ approach to
acceptability is the novelty of this research. Our methodology could be
applied to the assessment of a variety of microbicide gel
formulation attributes, for those targeting HIV only or those with
multiple prevention targets, such as unintended pregnancy, HIV,
and other infections. It could also further be extended to the field
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Methods
Both qualitative and quantitative data were collected to assess
user acceptability. Eligible subjects for this study were women aged
18–55 years old, who had had heterosexual sexual intercourse in
the previous 12 months. To assure a heterogeneous sample,
participants were recruited from various venues in Northern
California, including junior colleges that serve low-income, inner
city communities, universities and colleges with middle- and
upper-income student populations, community organizations and
clinics serving immigrant and low-income populations. Various
recruitment methods were used, including fliers posted throughout
college campuses, in clinics, and other community venues, and
announcements in classes, campus newspapers, and list-serves.
Focus group discussions (N=71) were administered by a trained
interviewer and audio-recorded and then transcribed. The
discussions lasted approximately 60 minutes and were conducted
in English. Transcripts were analyzed and coded to ascertain
common themes using the qualitative data analysis software
program ATLAS.ti (Version XX, The Knowledge Workbench.
Berlin, Scientific Software Development Inc.). Because of the
responsive nature of the discussions, each focus group was unique,
thus the actual coding list was refined as the coding took place.
Upon completion of the coding, a second researcher examined
both the final coding list and the actual coding of each transcript.
Any coding discrepancies were discussed between the two
researchers and coding was modified according to their agree-
ment. The discussions focused on women’s attitudes towards
existing sexual and reproductive health products, including HIV/
STI and pregnancy prevention methods and lubricants, attitudes
towards using a new STI prevention product, self-reported risk
factors for HIV, STIs, and pregnancy. We also explored inferred
microbicide preferences and how women would make trade-offs in
terms of their preference among products with different biophys-
ical characteristics. Participants were presented with a 5-minute
description of microbicides, and information of how microbicides
might be formulated and used. To help women visualize the
distinction between a ‘highly viscous’ gel and a ‘less viscous’ gel, the
interviewer showed participants several different over the counter
(OTC) products currently available and applied the products to her
own hand to illustrate viscosity. To illustrate a highly viscous gel,
Vagisil Regular Strength Anti-Itch (Combe, Inc.) cream was
demonstrated and to illustratea less viscous gel, KY Jelly (Johnson
& Johnson, Inc.) Personal lubricant was demonstrated. Next, the
women completed a brief questionnaire. The questionnaire had
three main components. The first component assessed self-reported
HIV/STI risk status and use of preventive methods. The second
section explored microbicide preferences and how women would
Increasing Vaginal Microbicides’ Effectiveness
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different biophysical characteristics. The third survey component
recorded socio-demographic variables. The survey was adminis-
tered by a trained interviewer and was self-administered following
the focus group discussions.
This present work focuses on the second component of the
questionnaire, in which we asked women three sets of questions to
explore the relationship between product acceptability and
biophysical properties of potential microbicide products. The
questions of this section were driven by the mathematical model
[19] used to assess the biophysical characteristics of the product.
The model was used to determine how coating rates would change
when physical attributes of the gel were changed. First, we asked a
‘time’ question to assess how likely (on a scale ranked from 1 to 7)
women would use each of three microbicides which varied by how
much time before sexual intercourse they needed to be applied.
The three distinct times, suggested by the model and physical
attributes in the ranges of candidate microbicides, were: 1/ 2–
15 minutes; 2/ 1 hour; 3/ 10 hours. Second, we asked a
‘thickness’ question, about how likely (on a scale ranked from 1
to 7) would women be, to use each of three microbicides varying
by their feeling of thickness upon application. The three distinct
feelings were: 1/ watery; 2/ slippery; 3/ thick. Third, we asked a
‘constrained’ question, about how likely (on a scale ranked from 1
to 7) women would use each of three microbicides. The latter
microbicides were three distinct combinations of ‘time’ and
‘thickness’: 1/ a watery microbicide for which the user would
have to wait for 2–15 minutes before sexual intercourse; 2/ a
slippery microbicide for which the user would have to wait 1 hour
before sexual intercourse; 3/ a thick microbicide for which the
user would have to wait 10 hours before sexual intercourse.
The time of spread of the gels was translated from viscosity data
from gels such as KY Jelly (Johnson & Johnson, Inc.),
Carraguard (The Population Council, Inc.), and HEC (placebo
gel used in the CAPRISA 004 trial [9]) etc. obtained from David
Katz and coworkers at Duke University (David Katz, Private
Communication) through a timescale proportional to g, where g is
a representative viscosity of the gel. The thickness of the gels was
expressed into sensations of ‘watery’, ‘slippery’ and ‘thick’ from
physical experiences with commercial gels and was linked to three
different viscosity scales coming from the common physical sense
that a watery gel has a low viscosity, that a thick gel has a high
viscosity etc. Lastly, the ‘constrained’ series of questions was simply
revealing the links among attributes of gels that derive from
biophysical constraints (i.e. if a gel is thick, it is going to have a
high viscosity and therefore it is going to take a longer time to
spread onto the vaginal epithelium).
Analysis of the questionnaire data was accomplished using R
statistical package R 2.10.1 (The R Project for Statistical
Computing, 2009. http://www.r-project.org/).
Table 1. Demographic and behavioral characteristics of the study population (N=71).
Characteristic Number of subjects* (%)
Age
.30 years old 38 54
#30 years old 32 46
Race/Ethnicity







Full time 24 38




Regular boyfriend/partner 24 36
Casual partner 21 31
Prevention methods used for STI or pregnancy prevention
Male condoms 66 93
Female condoms 57
Hormonal contraception 60 85
Hormonal contraception plus condoms 56 79
Other (e.g., spermicide, natural, etc) 39 55
History of STI diagnosis 22 31
History of an unplanned pregnancy 36 51
*Note: data are missing for up to 7 women because of failure of some women to complete specific questions in the questionnaire.
doi:10.1371/journal.pone.0015501.t001
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Demographics and behavioral characteristics of the
study population
Demographic and behavioral characteristics of the study
population are reported in table 1. The majority of the women
who participated were White (36%) followed by ‘mixed race’
(23%) and Hispanic (20%). Slightly less than half of the sample was
under 30 years of age (46%) and about a third of the women
reported having had casual sex partners in the past year (31%).
About half (51%) of the women reported having ever had an
unplanned pregnancy and 31% reported ever having had an STI.
While 93% reported ever using condoms and 79% reported ever
using condoms in combination with a hormonal method for birth
control, focus group discussions with these women suggested that
condom use was inconsistent, especially with longer-term partners.
Quantitative analysis
The distributions of the answers (scores) corresponding to the
series of questions ‘time’, ‘thickness’ and ‘constrained’ for use with
a steady partner and a casual partner are presented on figure 1.
Figure 2 displays the population means for the latter answers. The
answers were further analyzed using paired t-tests for the means.
We compared the scores of paired answers within each series of
questions for steady vs. casual partner. For each subject j, each
score was noted Xi,j (i=1, 2, 3 [1=2–15 min, 2=1 hr, 3=10 hr
for the ‘time’ series]; j=1,…, 71), leading to three answers X1,j, X2,j
and X3,j. We then estimated the 3 differences a, b and c for each
pair of scores: Da,j=X1,j2X2,j, Db,j=X1,j2X3,j and Dc,j=X2,j2X3,j





k=a, b,o rc and n is the number of answers. The t-test statistic was













2. The corresponding 95% confidence
intervals and p-values were then derived. Table 2 collects the
results.
Results indicate that users, whether with a steady or casual
partner, would prefer a gel that spreads very fast of the order of 2 to
15 minutes as compared with 1 hour or 10 hours (p,0.0001).
Likewise, they prefer a gel that is thick or slippery, as compared to
watery (p,0.02). Figure 2 and table 2 illustrate the preferences
when the subjects were asked the questions independently (i.e.
without making a trade-off). Subsequently, if asked the question
‘constrained’ by physical reality, the subjects in a steady relationship
tended to drop the unconstrained preferences for a thick gel and for
a gel that spreads rapidly. On average, the same subjects present a
more uniform distribution of preferences for any of the synthesiz-
able gels (p.0.10) (see figure 2 and table 2). On the contrary, the
data indicate that subjects in casual relationship would choose a gel
that spreads rapidly though watery rather than a gel that has
intermediate properties (p=0.024), without discarding a thick and
long spreading gel (p=0.908) (see figure 2 and table 2).
Qualitative analysis
Consistent with the quantitative findings, the qualitative data
indicates that regardless of relationship status, women would
prefer a product they can use spontaneously (i.e., within 2–
15 minutes after application) and one that is highly viscous, or
thick and not messy. However, when asked to make a trade-off
between a product they could use shortly after application but was
less viscous, similar to KY Jelly, compared to a thicker, more
viscous product with less leakage that would require application
several hours ahead of use to be effective, we saw differences
according to relationship status consistent with the quantitative
data. The findings suggest that among women in casual
relationships, if asked to make a trade-off between viscosity and
wait time, the priority for such women overall is to have a product
which could be effective quickly (little wait time), regardless of
viscosity. Indeed, when probed further, many women reported
that a less viscous microbicide could even be appealing if it could
enhance pleasure, such as a ‘warming’ gel or lubricant. Women in
steady relationships were more concerned about the effectiveness
of the product for prevention of pregnancy or STIs/HIV as it
would be easier for them to plan ahead compared to women being
in a casual relationship.
Discussion
We designed a conceptual study where for the first time the
behavioral acceptability of microbicide gels is realistically
constrained and interpreted through the biophysical reality of
the gels themselves. Specifically, we conclude that at the
population level there is a fairly uniform spectrum of preferences
for gels of different thicknesses (and so wait times) for women in a
steady relationship, and a preference for a gel that spreads very fast
as compared with a gel having intermediate properties for women
in a casual relationship. In that sense, developers should offer a
range of formulations in order to address the preferences of all
users and therefore increase adherence. Though our results are not
exhaustive due to the limitations of the sample size (N=71), and
although we would do well to incorporate a number of other
attributes, the work here still introduces a new approach in the
field. One could now use the latter approach to broaden the
conversation and include questions with more characteristics that
can govern gel coating such as pH, temperature [42] or
interference with sexual intercourse [43] etc. Also, one should
carry out such a new approach with different target populations
from racially and socio-economically diverse communities and
geographical regions, and most particularly with women at high
risk for HIV/STIs.
The approach is novel as it presents for the first time a critical
biophysical framework in which to rethink the acceptability of
microbicide gel vehicles. The latter framework would ensure that
end users like the gels’ features offered by market developers,
identifying individualized prevention strategies and generating the
highest usage rates. It will help refine and tailor the microbicide
gels’ application instructions given to participants of clinical trials,
and will help design future products that can achieve greater
compliance rates. This is important, as poor adherence can
contribute to the lack of effectiveness or reduced effectiveness
observed in the clinical trials [9,13,18]. In particular, one could
use this framework to study the trade-off between the user’s
preferences for microbicide physical attributes and adherence, in
looking at the sensitivity of adherence patterns to biophysical
attributes, revealing who uses microbicides correctly and consis-
tently, and which factors enhance or constraint such use.
Figure 1. Distributions for the scores to each of the biophysical attribute questions. The distributions are for both steady and casual
partners. a/ ‘Time steady’; b/ ‘Thickness steady’; c/ ‘Constraint steady’; d/ ‘Time casual’; e/ ‘Thickness casual’; f/ ‘Constraint casual’.
doi:10.1371/journal.pone.0015501.g001
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the biophysical and behavioral acceptability of the product can
contribute to more realistic designs for the future.
This work fits well into the new era of conceptualizing a
mechanistic model to guide microbicide development [44] and
with recent biophysical work on linking gel deployment and
distribution in the human vagina to the user’s acceptability [43].
In the meantime, we hope to duplicate and adapt this idea of
constraints secondary to biophysical considerations for thinking
about the acceptability of other drug delivery systems in the field
of sexual and reproductive health. For instance, a first step in
the field of microbicides would be to look at intravaginal rings
that can stay in place for periods up to three months and are
likely to show greater adherence [14]. One could envision
asking similar unconstrained and constrained preference
questions, where this time the discussion focused on the specific
delivery method for the microbicide. Likewise, this framework
could be duplicated within recent acceptability work of rectal
microbicides [45].
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Table 2. Results of the paired t-tests.
Paired answers Number of answers* Mean difference mD (95% CI) p-value
Steady Partner
Time series
mDa=mX{2–15 min}2mX{1 hr} 67 2.03 (1.48–2.58) ,0.0001
mDb=mX{2–15 min}2mX{10 hr} 66 2.38 (1.76–3.00) ,0.0001
mDc=mX{1 hr}2mX{10 hr} 67 0.31 (20.28–0.91) 0.295
Thickness series
mDa=mX{watery}2mX{slippery} 36 21.69 (22.59–20.80) ,0.0001
mDb=mX{watery}2mX{thick} 37 21.67 (22.43–20.93) ,0.0001
mDc=mX{slippery}2mX{thick} 66 20.05 (20.64–0.55) 0.879
Constrained series
mDa=mX{2/15 min/watery}2mX{1 hr/slippery} 66 0.23 (20.35–0.80) 0.434
mDb=mX{2/15 min/watery}2mX{10 hr/thick} 65 0.26 (20.51–1.03) 0.501
mDc=mX{1 hr/slippery}2mX{10 hr/thick} 65 0.03 (20.59–0.65) 0.921
Casual Partner
Time series
mDa=mX{2–15 min}2mX{1 hr} 41 2.24 (1.39–3.09) ,0.0001
mDb=mX{2–15 min}2mX{10 hr} 38 3.03 (2.15–3.90) ,0.0001
mDc=mX{1 hr}2mX{10 hr} 39 0.49 (20.32–1.29) 0.227
Thickness series
mDa=mX{watery}2mX{slippery} 36 21.22 (22.17–0.28) 0.016
mDb=mX{watery}2mX{thick} 37 21.32 (22.15–20.50) 0.002
mDc=mX{slippery}2mX{thick} 38 20.13 (20.81–0.54) 0.695
Constrained series
mDa=mX{2/15 min/watery}2mX{1 hr/slippery} 37 1.00 (0.14–1.86) 0.024
mDb=mX{2/15 min/watery}2mX{10 hr/thick} 35 0.49 (20.60–1.57) 0.908
mDc=mX{1 hr/slippery}2mX{10 hr/thick} 35 20.66 (21.66–0.35) 0.192
The paired t-tests are for the mean difference between two answers for each of the three series of questions i.e. ‘time’, ‘thickness’ and ‘constrained’ series, for both a
steady and casual partner.
*Note: not all women reported having a casual partner and data are missing for up to 6 women because of failure of some women to complete specific questionsi nt h e
questionnaire.
doi:10.1371/journal.pone.0015501.t002
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